RxDoctor Payments Data

Nasifa Rahman, MD

Psychiatry · Philadelphia, PANPI 1215074489

Payments from drug & device makers

$362in general payments, 2019–2025

Across 14 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$85
  • Otsuka America Pharmaceutical, Inc.$84
  • Sunovion Pharmaceuticals Inc.$53
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$47
  • Indivior Inc.$44
  • Luye Pharma (USA) Ltd.$26
  • plus $23 from 1 others

What the payments were for

  • Food & beverage$31587%
  • Education$4713%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$362 in reported general payments places this provider in the 60th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$133,701
Medicare patients
166
Services billed
1,933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LatudaLurasidone Hcl26$32,358
TrintellixVortioxetine Hydrobromide14$7,200
Clozapine21$5,417
Fluphenazine Hcl25$3,422
Buspirone Hcl124$2,381
Lurasidone Hcl34$1,977
Aripiprazole69$1,791
Ziprasidone Hcl38$1,619
Doxepin Hcl56$1,414
Olanzapine82$1,285
Quetiapine Fumarate95$1,225
Risperidone58$1,135
Divalproex Sodium39$996
Clonazepam37$740
Benztropine Mesylate73$718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sunovion Pharmaceuticals Inc.Latuda$53$32,35826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →